Follow the Pundits

Tag: JohnPaulson

Golden fortress in a rugged mountain landscape with glowing DNA strands and a lone investor silhouette, symbolizing John Paulson’s high-conviction bets on gold and biotech

🏔️ John Paulson 2025: From "Short of the Century" to the "Long of the Decade"

John Paulson is back. After years under the radar, the legendary investor posted a 58% return in 2025—driven by high-conviction bets in biotech, gold, and strategic minerals. This is not diversification. This is precision investing.

Read entire article

Tags: 13f analysis, event driven investing, EventDrivenInvesting, featured-hedge-funds, funanc1al, gold stocks, GoldInvesting, hedge funds, high conviction investing, hub-hedge, john paulson, JohnPaulson, macro investing, madrigal pharmaceuticals, MDGL, mining stocks, MiningStocks, PaulsonAndCo, perpetua resources, portfolio strategy, stock market insights, StockMarket2026, THM
Digital illustration of John Paulson standing atop a golden minecart loaded with gold bars and antimony atoms, surrounded by pine trees and American flags. Idaho mountains rise in the background. Caption: “Paulson’s Gold Rush?”

John Paulson Is Loading Up on Perpetua Resources. Should You?

John Paulson knows a good discount when he sees one—and he just grabbed another $100M worth of Perpetua Resources (PPTA). But what is this gold-and-antimony play really about? From Idaho mines to strategic minerals and a wink at squirrel invasions, we break it all down.

Read entire article

Tags: Antimony, Antimony Mining, best hedge funds, CriticalMinerals, Funanc1al, Funanc1al Edge, Funanc1al for Investors, Funanc1al Insider Series, Funanc1al Investing, Funanc1alEdge, Funanc1alHumor, Funanc1alInsiderSeries, Funanc1alInvesting, Funanc1alStocks, Gold Mining, GoldStocks, IdahoInvesting, insider buying, Insider Buys, Insider Purchases, InsiderActivity, InsiderBuy, InsiderBuying, InsiderBuys, InsiderPurchases, InsiderWatch, Investment Diversification, John Paulson, JohnPaulson, MiningStocks, Paulson & Co, PerpetuaResources, PPTA, PPTA Stock, SpeculativePlays, WatchlistWorthy
Infographic on Bausch Health (BHC) featuring John Paulson’s insider buy, stock chart, and pharma recovery symbols with a contrarian twist.

Bausch Health: Paulson Doubles Down, Stock Breaks Out, Recovery Accelerates

Bausch Health ($BHC) is back in the spotlight as legendary investor John Paulson adds millions more in shares, fueling a breakout rally. With Q2 earnings showing revenue growth, profit rebound, and debt repayment plans, could BHC be staging its long-awaited comeback?

Read entire article

Tags: BauschHealth, BHC, BHCStock, BiotechTurnarounds, CarlIcahn, CheapStocks, ContrarianPlay, DeepValue, DoubleDown, Funanc1al, Funanc1al Contrarian Picks, Funanc1al Contrarian Plays, Funanc1al Edge, Funanc1al for Investors, Funanc1al Insider Series, Funanc1al Investing, Funanc1al Turnaround Plays, Funanc1alEdge, Funanc1alFun, Funanc1alInsiderSeries, Funanc1alInvesting, Funanc1alStocks, HealthcareStocks, HedgeFundBuying, InsiderBuying, Investing, John Paulson, JohnPaulson, Paulson, PharmaStocks, SmartMoneyMoves, StockMarketHumor, StocksToWatch, StocksWithHistory, TurnaroundStocks